The lead investigators have also spun out a company, Isabl, aiming to make the approach available to the broader community.
The RT-LAMP-based platform, which the researchers plan to commercialize through a spinout company, could be adapted for other infectious disease tests.
Tiziana Life Sciences to Spin Off StemPrintER Asset Into Separate Company
The company, which originally announced plans for a possible spin off in June, will hold a shareholder meeting to vote on the details in October.
Seer Spins Out Disease Testing Firm PrognomIQ With $55M in VC Funding
The new company will use Seer's Proteograph proteomic platform along with other omics data to develop and commercialize tests for cancer and other diseases.
IDbyDNA Raises $20M in Series B Financing
The University of Utah spinout said it will use the funding to enhance and expand its NGS-based Explify microbe identification platform and support its lab.